B. Strober, “Deucravacitinib in Plaque Psoriasis: Maintenance of Response Over 3 Years in the Phase 3 POETYK PSO-1 and PSO-2 Trials”, J of Skin, vol. 7, no. 6, p. s241, Nov. 2023.